Skip to main content
Cannabis RadioCannabis Radio
ShowsDigital Marketing
Sign in

Loading...

Platform

  • All Shows
  • Search

Company

  • About
  • Contact

Legal

  • Privacy
  • Terms
  • Acceptable Use
  • DMCA Policy

© 2026 Cannabis Radio. All rights reserved.

Grassroots Marketing

HEMPFLAVIN Clinical Study And Effect on Acute and Chronic Pain Patients

March 28, 202220 min

HEMPFLAVIN Clinical Study And Effect on Acute and Chronic Pain Patients

Grassroots Marketing

0:00--:--

Dr. Donato Borrillo and Brian Dickerson, the CEO of Doctor’s Hemp Solutions discuss a new clinical study on HEMPFLAVIN and its effect on acute and chronic pain patients, with zero side effects. HEMPFLAVIN, a proprietary blend of twenty-three (23) Cannflavins and flavonoids extracted from an heirloom hemp variety which is over 2,000 years old, is formulated to be used for severe body aches, muscle soreness and other pain relief by creating a synergistic flavonoid response known as the “flavonoid entourage effect”. The flavonoids in HEMPFLAVIN include Cannflavin A, B, & C, Cannabisin A, B & C, quercetin, apigenin-7- and kaempferol. Previous studies have found that the flavonoids in HEMPFLAVIN have prominent anti-inflammatory action and may help augment the body’s antioxidant defense. The new clinical study conducted by Dr. Donato Barrillo focused on the effect of flavonoids, specifically the Cannflavins, which make up less than 0.15% of the fresh weight of cannabis. To date, a massive amount of cannabis would have to be consumed in order for the effects of this component to take place; however, a proprietary extraction technique has resulted in the production of HEMPFLAVIN, with microgram quantities dosing thereby producing an observable clinical effect. For more information, visit http://www.hempflavin.com / and https://www.doctorshempsolutions.com .

Enjoy this episode?

Subscribe to Grassroots Marketing for new episodes.

More from Grassroots Marketing

Hemp on the Brink: Toby Streett's Call to Action on the Total THC Limit

Hemp on the Brink: Toby Streett's Call to Action on the Total THC Limit

Grassroots Marketing

Toby Streett, the founder of Cbdeeme explained the critical issues facing the hemp industry, detailing how the proposed Farm Bill's total THC limit threatens the $24 billion market and the need for urgent consumer and congressional…

Dec 28, 202530 min
Navigating Cannabis's Regulated Future and Growth Opportunities with Jen Lamboy

Navigating Cannabis's Regulated Future and Growth Opportunities with Jen Lamboy

Grassroots Marketing

Hybrid Marketing Co.'s VP of Strategy, Jen Lamboy, offered a deep dive into the complex, state-by-state regulated U.S. cannabis market, highlighting that managing diverse consumer types and cultural stigma is key to success.

Dec 28, 202520 min
Hemp's Unintended High: Regulation Gaps and Indigenous Ethical Growth

Hemp's Unintended High: Regulation Gaps and Indigenous Ethical Growth

Grassroots Marketing

Eric Steenstra discussed the complex federal journey of hemp legalization, highlighting the shift from the 2014 Farm Bill's original non-intoxicating intent to the unintended conversion of CBD into intoxicating cannabinoids like Delta 8…

Dec 28, 202520 min
Sinful's High-Dose Beverages and Strategic US Expansion: Inside Montana's Top Cannabis Brand

Sinful's High-Dose Beverages and Strategic US Expansion: Inside Montana's Top Cannabis Brand

Grassroots Marketing

James Stephens, co-founder of Sinful, shared insights on his company's success as Montana's top-selling cannabis brand, which specializes in premium THC beverages and gummies. The discussion covered Sinful's strategic expansion plans into…

Dec 21, 202514 min
Loading comments...